Differences in β3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 3, 1996, Pages 1435-1443

  Shen, You Tang ^a,b   Cervoni, Peter ^a,c   Claus, Thomas ^a,d   Vatner, Stephen F ^a,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c PFIZER INC   (United States)

^d BAYER CORPORATION   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; ATROPINE METHYL BROMIDE; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CEFALOTIN; FATTY ACID; GLYCERYL TRINITRATE; HALOTHANE; HEXAMETHONIUM BROMIDE; PHENYLEPHRINE; PROPRANOLOL; THIAMYLAL; XYLAZINE;

ANIMAL EXPERIMENT; ARTICLE; BABOON; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; DOG; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE DP-DT; HEART OUTPUT; HEART RATE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; MONKEY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE;

ADRENERGIC BETA-AGONISTS; ANIMALS; DIOXOLES; DOGS; ETHANOLAMINES; FATTY ACIDS, NONESTERIFIED; FEMALE; HEMODYNAMIC PROCESSES; LIPOLYSIS; MACACA FASCICULARIS; MALE; PAPIO; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3; SPECIES SPECIFICITY; WAKEFULNESS;

EID: 0030438465     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ARCH, J. R. S., AINSWORTH, A. T., CAWTHORNE, M. A., PIERCY, V., SENNITT, M. V., THODY, V. E., WILSON, C. AND WILSON, S.: Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309: 163-165, 1984.
2. 3 and atypical β-adrenoceptors. Med. Res. Rev. 13: 663-729, 1993.
3. 3-adrenergic receptor - a cause and cure of obesity? N. Engl. J. Med. 333: 382-383, 1995.
4. 3-receptors: A promising antidiabetic and antiobesity agent. J. Med. Chem. 35: 3081-3084, 1992.
5. BOND, R. A. AND CLARKE, D. E.: A response to isoprenaline unrelated to α- and β-adrenoceptor agonism. Br. J. Pharmacol. 91: 683-686, 1987.
6. BOND, R. A. AND CLARKE, D. E.: Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the α-and β-subtypes. Br. J. Pharmacol. 95: 723-734, 1988.
7. 3 adrenergic receptors to brown fat adenylyl cyclase. J. Pharmacol. Exp. Ther. 261: 633-637, 1992.
8. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N. Engl. J. Med. 333: 352-355, 1995.
9. 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol. Endcrinol. 8: 518-527, 1994.
10. DOLAN, J. A., MUENKEL, H. A., BURNS, M. G., PELLEGRINO, S. M., FRASER, C. M., PIETRI, F., STROSBERG, A. D., LARGIS, E. E., DUTIA, M. D., BLOOM, J. D., BASS, A. S., TANIKELLA, T. K., COBUZZI, A., LAI, F. M. AND CLAUS, T. H.: β-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines. J. Pharmacol. Exp. Ther. 269: 1000-1006, 1994.
11. 3-adrenoceptor: The search for a physiological function. Trends Pharmacol. Sci. 15: 3-7, 1994.
12. 3-adrenergic receptor. Science 245: 1118-1121, 1989.
13. 3-adrenergic receptor: relationship with atypical receptors. Am. J. Clin. Nutr. 56: 215s-218s, 1992.
14. 3-adrenergic receptor. Mol. Pharmacol. 40: 895-899, 1991.
15. HOLLENGA, C., HAAS, M., DEINUM, J. T. AND ZAAGSMA, J.: Discrepancies in lipolytic activities induced by β-adrenoceptor agonists in human and rat adipocytes. Horm. Metabol. Res. 22: 17-21, 1990.
16. LANDS, A. M., ARNOLD, A., MCAULIFF, J. P., LUDUENA, F. P. AND BROWN, T. G.: Differentiation of receptor systems activated by sympathomimetic amines. Nature 214: 597-598, 1967a.
17. LANDS, A. M., LUDUENA, F. P. AND BUZZO, H. J.: Differentiation of receptors responsive to isoproterenol. Life Sci. 6: 2241-2249, 1967b.
18. LANGIN, D., PORTILLO, M. P., SAULNIER-BLACHE, J-S. AND LAFONTAN, M.: Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species. Eur. J. Pharmacol. 199: 291-301, 1991.
19. 3-adrenoceptor in man. Br. J. Pharmacol. 110: 929-936, 1993.
20. 3-adrenoceptors in obesity. J. Clin. Invest. 95: 1109-1116, 1995.
21. 3 adrenergic receptors. J. Clin. Invest. 95: 923, 1995.
22. LOWELL, B. B., SUSULIC, V. S-., HAMANN, A., LAWITTS, J. A., HIMMS-HAGEN, J., BOYER, B. B., KOZAK, L. P. AND FLIER, J. S.: Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366: 740-742, 1993.
23. MUZZIN, P., REVELLI, J-P., KUHNE, F., GOCAYNE, D., MCCOMBIE, W. R., VENTERS, J. C., GIACOBINO, J. P. AND FRASER, C. M.: An adipose tissue-specific β-adrenergic receptor. J. Biol. Chem. 266: 24053-24058, 1991.
24. 3-adrenergic effect on lipolysis in human subcutaneous adipose tissue. J. Clin. Endocrinol. Metab. 77: 352-355, 1993.
25. SHEN, Y-T., ZHANG, H. AND VATNER, S. F.: Peripheral vascular effects of β-3 adrenergic receptor stimulation in conscious dogs. J. Pharmacol. Exp. Ther. 268: 466-473, 1994.
26. STROSBERG, A. D.: Biotechnology of β-adrenergic receptors. Mol. Neurobiol. 4: 211-250, 1990.
27. TAKAHASHI, H., YOSHIDA, T., NISHIMURA, M., NAKANISHI, T., KONDO, M. AND YOSHIMURA, M.: Beta3-adrenergic agonist, BRL-26830A, and alpha/beta blocker, arotinolol, markedly increase regional blood flow in the brown adipose tissue in anesthetized rats. Jpn. Circ. J. 56: 936-942, 1992.
28. 3-adrenoceptor agonists does not involve cardiac β-adrenoceptors but baroflex mechanisms. J. Pharmacol. Exp. Ther. 263: 1083-1090, 1992.
29. 3-adrenergic-receptor gene. N. Engl. J. Med. 333: 343-347, 1995.
30. 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N. Engl. J. Med. 333: 348-351, 1995.
31. 3-adrenoceptor'? Trends Pharmacol. Sci. 11: 3-7, 1990.